QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 发表日期：2016     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 卷号: 9 作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting 收藏  |  浏览/下载：36/0  |  提交时间：2019/01/08 Anlotinib  Anti-angiogenesis  Phase I study  Advanced refractory solid tumors  Pharmacokinetics  Safety   Equine Immunoglobulin and Equine Neutralizing F(ab)(2) Protect Mice from West Nile Virus Infection 期刊论文 VIRUSES-BASEL, 2016, 卷号: 8, 期号: 12 作者:  Qiu, Boning;  Cui, Jiannan;  Zhao, Yongkun;  Wang, Hualei;  Cao, Zengguo 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05 West Nile virus  equine immunoglobulin  F(ab)(2) fragments  mice   A study on the association between hyperlipidemia and hypothyroidism and the response to TKIs in metastatic renal cell carcinoma 期刊论文 2016, 卷号: 12, 期号: 2, 页码: 174-180 作者:  Song, Yan;  Du, Chunxia;  Zhang, Wen;  Sun, Yongkun;  Yang, Lin 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 hyperlipidemia  hypothyroidism  renal cell carcinoma  tyrosine kinase inhibitor   Body mass index and age are additional prognostic factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors 期刊论文 2016, 卷号: 34, 期号: 6, 页码: 258.e15-22 作者:  Song, Yan;  Du, Chunxia;  Zhang, Wen;  Sun, Yongkun;  Yang, Lin 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Renal cell carcinoma  Kidney  Tyrosine kinase inhibitors  Prognosis   Adaptive amino acid substitutions enhance the virulence of a novel human H7N9 influenza virus in mice 期刊论文 2016, 卷号: 187, 页码: 8-14 作者:  Zhao, Yongkun;  Yu, Zhijun;  Liu, Linna;  Wang, Tiecheng;  Sun, Weiyang 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Amino acid substitutions  Virulence  H7N9 influenza virus  Mouse model   Phase II study of anlotinib for treatment of advanced soft tissues sarcomas. 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Chi, Yihebali;  Sun, Yongkun;  Cai, Jianqiang;  Yao, Yang;  Hong, Xiaonan 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Phase II study of anlotinib for treatment of advanced medullary thyroid carcinoma. 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Sun, Yongkun;  Chi, Yihebali;  Tang, Pingzhang;  Gao, Ming;  Ji, Qinghai 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Phase II study of anlotinib for treatment of advanced medullary thyroid carcinoma. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Sun, Yongkun;  Chi, Yihebali;  Tang, Pingzhang;  Gao, Ming;  Ji, Qinghai 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 Phase II study of anlotinib for treatment of advanced soft tissues sarcomas. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Chi, Yihebali;  Sun, Yongkun;  Cai, Jianqiang;  Yao, Yang;  Hong, Xiaonan 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/04 Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文 2016, 卷号: 9, 期号: 1, 页码: 105 作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Anlotinib  Anti-angiogenesis  Phase I study  Advanced refractory solid tumors  Pharmacokinetics  Safety